B

Baroness Merron (Lab)

Speaking in the House of Lords on 15 June 2026

Debate

Rare Cancers: Diagnosis and Treatment

Contribution

I recognise what the noble Lord says about bottlenecks. That is why the national cancer plan is quite clear about the changes we will see. I should say, to the point in this Question, that there is for the first time specific reference to rare cancers—I always think “rare cancers” is a bit of a misnomer in any case, if one looks at the statistics. The national cancer plan also sets out a major expansion in the use of genomics, and that will support earlier diagnosis and more personalised treatment. That is what we need to see.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites